Navigation Links
3rd international conference on innovative approaches in head and neck oncology
Date:2/1/2011

The European Society for Therapeutic Radiology and Oncology (ESTRO), the European Head and Neck Society (EHNS), and the European Society for Medical Oncology (ESMO) in collaboration with other European partners, have the pleasure of inviting you to report on the 3rd International Conference on innovative approaches In Head and Neck Oncology.

With major emphasis on multidisciplinarity and innovation, this meeting will specifically cover the main following topics:

  • Biological patient profiling and risk factors
  • Emerging diagnostic and therapeutic tools
  • Functional outcome of treatments
  • Global care of patients (cultural issues, psychosocial support, what do patients expect, etc)
  • Clinical controversies based on case discussions such as Evidence-based medicine or practice based medicine, etc

More information on the conference: http://www.estro-events.org/Pages/ichno2011.aspx

More information on Head & Neck cancers on the Radiotherapy Information Centre: http://www.estro-ric.org/media/Pages/HeadandNeckCancer.aspx#Head%20&%20Neck%20cancers

Tremendous achievements in Head & Neck cancers

Head and neck cancers together make up 5% of all cancers diagnosed each year 120,000(1) across Europe. The most common head and neck cancers are:

  • the mouth and tongue (oral cavity)
  • the back of the throat (pharynx)
  • the voice box (larynx)
  • the sinuses

Oral cancers represent 3% of new cases in the UK and 6% in France; while in Sri Lanka, India, Pakistan and Bangladesh, oral cancer is the most common cancer in men and may account for up to 30% of all new cases of cancer (2).

But over the last decade, tremendous achievements have been made in the management of patients with Head & Neck Cancer. Advancements in the understanding of the pathogenesis of Head & Neck malignancies could rapidly lead to the elaboration of tailored treatments:

  • Functional imaging has emerged as a complementary modality to anatomic imaging methods for better staging,
  • Treatment response evaluation and optimal treatment targeting are evolving,
  • Surgery has improved markedly, in particular with better reconstruction techniques moving the limit of operability further.
  • Randomised studies have demonstrated the increasing role of combined modality approaches with chemotherapy and biological targeted therapies.
  • New radiation techniques, expected to impact on survival and quality of life of Head & Neck patients, have taken off the ground

And this is just the beginning, with many more challenges ahead of us.

(1,2) Source: European Society for Therapeutic Radiology and Oncology (ESTRO) 2008, www.estro-ric.org

Media registration

You can pre-register now by writing to cecile.hardon@estro.org. On-site registration is possible at the Press Registration Desk. You will be asked for your press card and a letter of assignment.


'/>"/>

Contact: Cecile Hardon-Villard
cecile.hardon@estro.org
322-775-9340
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Lung societies unveil new international classification of lung adenocarcinoma
2. American Chemical Society unveils International Year of Chemistry virtual journal
3. International community called upon to stop the runaway train of cancer in Africa
4. Biodesign hosts international consortium on screening for lung cancer
5. Pier Paolo Pandolfi, M.D., Ph.D., to receive Pezcoller-AACR International Award for Cancer Research
6. International research team reports major findings in prevention and treatment of blood clots
7. International consortium to examine the impact of medical devices on health and retirement
8. New international conference in bionic engineering
9. International clinical trial tests targeted drug for melanoma
10. Experts present new testing methods at international meeting in New Orleans, Nov. 14-18
11. Half of those travelling internationally not aware of potential health risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Houston, TX (PRWEB) , ... February 24, 2017 ... ... now offering promotions on tooth replacement options at his office, Antoine Dental Center. ... dental implants for $18,499. Some restrictions may apply, but patients can learn more ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
(Date:2/24/2017)... New York, NY (PRWEB) , ... February 24, 2017 , ... ... urges: “Security needs to be a top priority because it’s not if you will ... in online safety, especially when it comes to digital health care. , Improvements in ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... concerning this present generation. Yisrayl makes an astounding statement when he says that ... explains that the Bible details the current times so plainly that anyone should be ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  This report analyzes the worldwide markets for ... Products: Intermediates, Analytical, and Others. The End ... and Agrochemicals. The report provides separate comprehensive analytics for ... Europe , and Rest of World. Annual estimates ... 2022. Also, a six-year historic analysis is provided for ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis and ... global Urinary Incontinence market. The research answers the following questions: ... for Urinary Incontinence and their clinical attributes? How are they positioned ...
(Date:2/23/2017)... MINNEAPOLIS , Feb. 23, 2017  Cogentix Medical, ... manufactures and markets innovative proprietary products for the urology ... and fiscal year ended December 31, 2016 before the ... The Company will host a conference call and ... on Thursday, March 9, 2017 at 11:00 a.m. Eastern ...
Breaking Medicine Technology: